Orion Infusion Limited (DSE:ORIONINFU)
Bangladesh
· Delayed Price · Currency is BDT 365.00
-14.60 (-3.85%)
At close: Dec 4, 2025
Orion Infusion Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| Revenue | 631.54 | 664.92 | 827.42 | 810.15 | 829.57 | 727.4 | Upgrade
|
| Revenue Growth (YoY) | -20.08% | -19.64% | 2.13% | -2.34% | 14.05% | -1.82% | Upgrade
|
| Cost of Revenue | 365.78 | 386 | 493.27 | 483.93 | 490.03 | 430.36 | Upgrade
|
| Gross Profit | 265.77 | 278.92 | 334.15 | 326.23 | 339.54 | 297.04 | Upgrade
|
| Selling, General & Admin | 184.83 | 194.84 | 250.01 | 247.8 | 246.98 | 215.97 | Upgrade
|
| Operating Expenses | 184.83 | 194.84 | 250.01 | 247.8 | 246.98 | 215.97 | Upgrade
|
| Operating Income | 80.94 | 84.09 | 84.14 | 78.43 | 92.56 | 81.07 | Upgrade
|
| Interest Expense | -37.17 | -39.76 | -32.72 | -27.19 | -26.64 | -26.3 | Upgrade
|
| Interest & Investment Income | 0.24 | 0.22 | 0.43 | 0.21 | 0.35 | 0.15 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | -0.64 | -0.7 | -1.11 | -1.77 | -0.85 | Upgrade
|
| EBT Excluding Unusual Items | 43.95 | 43.91 | 51.15 | 50.34 | 64.5 | 54.07 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.84 | 0.15 | -0.04 | -0.04 | 0.82 | -1.77 | Upgrade
|
| Pretax Income | 44.79 | 44.06 | 51.11 | 50.3 | 65.32 | 52.3 | Upgrade
|
| Income Tax Expense | 9.16 | 9.03 | 8.78 | 8.4 | 22.5 | 24.42 | Upgrade
|
| Net Income | 35.63 | 35.02 | 42.33 | 41.9 | 42.82 | 27.88 | Upgrade
|
| Net Income to Common | 35.63 | 35.02 | 42.33 | 41.9 | 42.82 | 27.88 | Upgrade
|
| Net Income Growth | -10.85% | -17.27% | 1.03% | -2.15% | 53.57% | -6.10% | Upgrade
|
| Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| EPS (Basic) | 1.75 | 1.72 | 2.08 | 2.06 | 2.10 | 1.37 | Upgrade
|
| EPS (Diluted) | 1.75 | 1.72 | 2.08 | 2.06 | 2.10 | 1.37 | Upgrade
|
| EPS Growth | -10.85% | -17.27% | 1.03% | -2.15% | 53.57% | -6.10% | Upgrade
|
| Free Cash Flow | 29.41 | 20.66 | 46.04 | -7.25 | 26.01 | 6.42 | Upgrade
|
| Free Cash Flow Per Share | 1.45 | 1.01 | 2.26 | -0.36 | 1.28 | 0.32 | Upgrade
|
| Dividend Per Share | 2.000 | 2.000 | 1.200 | 1.000 | 2.000 | 1.000 | Upgrade
|
| Dividend Growth | 66.67% | 66.67% | 20.00% | -50.00% | 100.00% | - | Upgrade
|
| Gross Margin | 42.08% | 41.95% | 40.38% | 40.27% | 40.93% | 40.84% | Upgrade
|
| Operating Margin | 12.82% | 12.65% | 10.17% | 9.68% | 11.16% | 11.14% | Upgrade
|
| Profit Margin | 5.64% | 5.27% | 5.12% | 5.17% | 5.16% | 3.83% | Upgrade
|
| Free Cash Flow Margin | 4.66% | 3.11% | 5.56% | -0.90% | 3.14% | 0.88% | Upgrade
|
| EBITDA | 90.96 | 96.49 | 99.51 | 93.82 | 103.03 | 91.16 | Upgrade
|
| EBITDA Margin | 14.40% | 14.51% | 12.03% | 11.58% | 12.42% | 12.53% | Upgrade
|
| D&A For EBITDA | 10.02 | 12.4 | 15.37 | 15.39 | 10.47 | 10.09 | Upgrade
|
| EBIT | 80.94 | 84.09 | 84.14 | 78.43 | 92.56 | 81.07 | Upgrade
|
| EBIT Margin | 12.82% | 12.65% | 10.17% | 9.68% | 11.16% | 11.14% | Upgrade
|
| Effective Tax Rate | 20.45% | 20.50% | 17.17% | 16.70% | 34.45% | 46.69% | Upgrade
|
| Advertising Expenses | - | 2.5 | 2.69 | 2.67 | 3.11 | 2.74 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.